Video Experimental Relacionado

Updated: Jan 29, 2026

Isolation of Mouse Endometrial Epithelial and Stromal Cells for In Vitro Decidualization

Isolation of Mouse Endometrial Epithelial and Stromal Cells for In Vitro Decidualization

Published on: March 2, 2017

Análisis mutacional integrado del sarcoma del estroma endometrial

Tobias M P Hartwich¹, Seungji Choi², Ayoung Hwang²

¹Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06510.

Proceedings of the National Academy of Sciences of the United States of America

|January 27, 2026

Resumen

Este estudio revela diferencias genéticas clave entre el sarcoma del estroma endometrial (ESS) de bajo y alto grado, identificando la amplificación de RAD54B como un impulsor y sugiriendo terapias dirigidas para este raro cáncer uterino.

Área de la Ciencia:

Genómica; Oncología; Biología Molecular

Sus antecedentes:

El sarcoma del estroma endometrial (ESS) es una neoplasia uterina rara con estrategias terapéuticas limitadas.
La comprensión de los fundamentos moleculares del ESS es crucial para el desarrollo de tratamientos eficaces.

Objetivo del estudio:

Caracterizar exhaustivamente el panorama genético del sarcoma del estroma endometrial (ESS) mediante secuenciación genómica y transcriptómica integrada.
Identificar impulsores moleculares distintos y vulnerabilidades terapéuticas en los subtipos de bajo grado (LG-ESS) y alto grado (HG-ESS).

Principales métodos:

Secuenciación integrada del genoma completo, exoma completo y transcriptoma de 80 tumores de ESS (32 LG-ESS, 48 HG-ESS).
Análisis de la carga mutacional, alteraciones del número de copias, fusiones génicas y desregulación de vías.
Estudios de modelos de xenoinjerto para la evaluación de terapias dirigidas.

Principales resultados:

Identificó la amplificación de RAD54B como un impulsor oncogénico en el 18,8 % de los tumores de ESS, lo que se correlaciona con una menor supervivencia.
Descubrió perfiles genéticos distintos: el HG-ESS mutó frecuentemente supresores de tumores (PTEN, TP53) y perdió reguladores del ciclo celular, mientras que el LG-ESS presentó fusiones canónicas (por ejemplo, JAZF1-SUZ12) y deleciones de genes metabólicos.
Seis casos de ESS hipermutados (7,5 %) con mutaciones en POLE o en la reparación de desajustes sugieren una posible respuesta a la inmunoterapia.
Demostró una supresión tumoral y una extensión de la supervivencia significativas en un xenoinjerto con mutación NRAS utilizando la inhibición combinada de MEK y FAK.

Conclusiones:

Este análisis genómico integral define la heterogeneidad molecular del ESS, diferenciando entre LG-ESS y HG-ESS.
La amplificación de RAD54B es un nuevo impulsor oncogénico en el ESS, y las alteraciones moleculares específicas apuntan a vulnerabilidades terapéuticas distintas.
Los hallazgos proporcionan una sólida base preclínica para el desarrollo de terapias de precisión, incluida la inmunoterapia y los agentes dirigidos, para pacientes con ESS.

Palabras clave:

ARNsec sarcomas del estroma endometrial panorama mutacional secuenciación del exoma completo secuenciación del genoma completo

Más Videos Relacionados

Isolation of Human Endometrial Stromal Cells for In Vitro Decidualization

Isolation of Human Endometrial Stromal Cells for In Vitro Decidualization

Published on: September 1, 2018

Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens

Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens

Published on: May 23, 2014

Videos de Conceptos Relacionados

Mutations

Mutations

Mutations

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Mutation, Gene Flow, and Genetic Drift

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).

Mutations in Microorganisms

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...

Point and Frameshift Mutations

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...